Full Text View
Tabular View
No Study Results Posted
Related Studies
Shock Trial: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.
This study has been completed.
Study NCT00000552   Information provided by National Heart, Lung, and Blood Institute (NHLBI)
First Received: October 27, 1999   Last Updated: January 15, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cardiovascular Diseases
Coronary Disease
Heart Diseases
Myocardial Infarction
Myocardial Ischemia
Shock, Cardiogenic
Additional conditions recognized in this trial
Coronary Artery Disease
Infarction
Ischemia
Shock
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Necrosis
Pathologic Processes
Vascular Diseases
Interventions listed in this trial
coronary artery bypass
thrombolytic therapy
Additional drug interventions recognized in this trial
Fibrinolytic Agents
More general drug interventions related to this trial
Cardiovascular Agents
Fibrin Modulating Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Heart, Lung, and Blood Institute (NHLBI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services